tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Zegbeh Jallah, 124 are a BUY (95.38%), 6 are a HOLD (4.62%).
Analyst Zegbeh Jallah, currently employed at CAPITAL ONE, carries an average stock price target met ratio of 32.59% that have a potential upside of 33.93% achieved within 220 days. Previously, Zegbeh Jallah worked at ROTH.
Zegbeh Jallah’s has documented 251 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 27-Dec-2023.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $8 was fulfilled within 5 days with a profit of $5.19 (184.7%) receiving and performance score of 369.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 25-Oct-2022
3 years 3 months 30 days ago
(25-Oct-2022)
1/10 (10%)
$13.99 (348.88%)
848
Hold Since 25-Oct-2022
$0.4
$0.01 (2.56%)
3 years 3 months 30 days ago
(25-Oct-2022)
1/1 (100%)
$0.01 (2.56%)
2
Hold Since 06-May-2020
3 years 4 months ago
(24-Oct-2022)
0/2 (0%)
$2.73 (29.45%)
Hold
3 years 4 months ago
(24-Oct-2022)
0/1 (0%)
$7.55 (308.16%)
Hold Since 29-Sep-2022
$11
3 years 4 months 26 days ago
(29-Sep-2022)
0/2 (0%)
$6.72 (157.01%)
What Year was the first public recommendation made by Zegbeh Jallah?
